Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation
Éolia Brissot(Inserm), Mohamad Mohty(Sorbonne Université), Jordi Esteve(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Alexandros Spyridonidis(General University Hospital of Patras), Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), Fabio Ciceri(Vita-Salute San Raffaele University), Jurjen Versluis(Erasmus MC), Ali Bazarbachi(American University of Beirut), Roni Shouval(Memorial Sloan Kettering Cancer Center), Jaime Sanz(Hospital Universitari i Politècnic La Fe), Myriam Labopin(Sorbonne Université), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Christoph Schmid(University Hospital Augsburg), Norbert Claude Gorin(Sorbonne Université), Arnon Nagler(Sheba Medical Center), Zinaida Perić(University of Rijeka), Maria Gilleece(Leeds Teaching Hospitals NHS Trust), Annalisa Ruggeri(Inserm), Gesine Bug(Goethe University Frankfurt), Bipin N. Savani(Vanderbilt University Medical Center), Frédéric Baron(University of Liège)
Cited by 74
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859